Clinical Trials
30 trialsLiver Transplantation for Non-resectable Colorectal Liver Metastases: Translational Research
Hospital Vall d'Hebron
Durvalumab (MEDI4736) and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver Transplant
University of Cincinnati
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
RIS-TH
Assistance Publique - Hôpitaux de Paris
LITALHICA
Azienda Sanitaria Ospedaliera
TESLA II
Oslo University Hospital
LSM
Assistance Publique - Hôpitaux de Paris
Downstaging Protocol Containing Immunotherapy for HCC Beyond the Milan Criteria Before Liver Transplantation
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
EXCALIBUR1+2
Oslo University Hospital
Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma
University Health Network, Toronto
TRANSMET
Assistance Publique - Hôpitaux de Paris
Liver Transplantation and Colorectal Cancer
Oslo University Hospital
Impact of Graft Reconditioning With Hypothermic Machine Perfusion on HCC Recurrence After Liver Transplantation
Azienda Ospedaliero-Universitaria di Modena
Partial Liver Segment 2/3 Transplantation Study
Oslo University Hospital
SECAIII
Oslo University Hospital
LIRICA
Azienda Sanitaria Ospedaliera
Liver Transplantation and Metastatic Colo-rectal Cancer.
Oslo University Hospital
EVOLVE
Oslo University Hospital
Liver Transplantation for Non-Resectable Intrahepatic Cholangiocarcinoma: a Prospective Exploratory Trial (TESLA Trial)
Oslo University Hospital
COLT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
HepatoPredict
Centro Hospitalar de Lisboa Central
TRANSGIST
Hospital Universitario Virgen de la Arrixaca
Liver Transplantation for Non-Resectable Colorectal Liver Metastasis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
TRANSPHIL
Assistance Publique - Hôpitaux de Paris
Expansion of Conventional Criteria for Liver Transplantation in Hepatocellular Carcinoma Through Downstaging
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
MELODIC
Azienda Ospedaliera di Padova
Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Stanford University
Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
Huazhong University of Science and Technology
Liver Transplantation for Cholangiocarcinoma
University of Utah
Liver Transplantation for Hilar Cholangiocarcinoma in Association With Neoadjuvant Radio- and Chemo-therapy
Azienda Ospedaliera di Padova